- Recent Funding
- Investors
- Pictet Alternative Advisors
Pictet Alternative Advisors portfolio
Pictet Alternative Advisors has 3 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months. Its most recent investment on record is Kinaset Therapeutics's $103M Series B+ round in January 2026, alongside Willett Advisors LLC, Vivo Capital, Sixty Degree Capital and 6 others. By category, its portfolio leans toward Health and bio (3) and AI agents (1). It has co-invested with Schroders Capital, RA Capital Management and Willett Advisors LLC, most often Schroders Capital (2 rounds).
What Pictet Alternative Advisors invests in
- Health and bio · 3 · 100%
- AI agents · 1 · 33%
- Education · 1 · 33%
Pictet Alternative Advisors recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $103M | Willett Advisors LLC, Vivo Capital, Sixty Degree Capital +6 | ||
| Series B+ · $150M | Seroba Life Sciences, Schroders Capital, Jeito Capital (lead) +2 | ||
| Series B+ · $270M | T. Rowe Price, NVentures, Modi Ventures +6 |
How Pictet Alternative Advisors invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 3 100% | $523M |
Share is of the 3 rounds on Recent Funding that name Pictet Alternative Advisors. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Pictet Alternative Advisors portfolio companies
KKinaset Therapeutics$103MSeries B+ · Jan 2026
AAzafaros$150MSeries B+ · May 2025
GGenerate Biomedicines$270MSeries B+ · Sep 2023
| Company | Round with Pictet Alternative Advisors | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $103M | $143M | Jan 9, 2026 Series B+ |
AI agents |
Series B+ · $150M | $177M | May 13, 2025 Series B+ |
Health and bio |
Series B+ · $270M | $640M | Sep 14, 2023 Series B+ |
Most frequent co-investors
SSchroders Capital2 shared rounds · last Jan 9, 2026
RRA Capital Management1 shared round · last Jan 9, 2026
WWillett Advisors LLC1 shared round · last Jan 9, 2026
VVivo Capital1 shared round · last Jan 9, 2026
AAtlas Venture1 shared round · last Jan 9, 2026
SSixty Degree Capital1 shared round · last Jan 9, 2026
GGimv1 shared round · last Jan 9, 2026
FForge Life Science Partners1 shared round · last Jan 9, 2026
EEQT Life Sciences1 shared round · last Jan 9, 2026
BBioGeneration Ventures1 shared round · last May 13, 2025
JJeito Capital1 shared round · last May 13, 2025
FForbion Capital Partners1 shared round · last May 13, 2025
Similar investors
PPositive Sum3 companies · 4 deals in 12 mo
IInnovestor3 companies · 3 deals in 12 mo
FFrazier Life Sciences3 companies · 2 deals in 12 mo
GGoHub Ventures3 companies · 2 deals in 12 mo
HHealthier Capital3 companies · 2 deals in 12 mo
KKadmos Capital3 companies · 2 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
Portfolio companies are the companies on Recent Funding with a round that lists Pictet Alternative Advisors, which is a subset of its real portfolio. API: /api/v1/investors/pictet-alternative-advisors (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy